Analytical Data
-
基因名
WAS
- Application
-
别名
Wiskott-Aldrich syndrome protein(WASp)
-
种属
Human
-
表达系统
Yeast
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P42768
-
表达区间
2-502aa
-
分子量
53.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WAS (Wiskott-Aldrich Syndrome) protein is an essential cytoskeletal regulator involved in immune cell function, particularly in T cells and platelets. Mutations in the WAS gene lead to Wiskott-Aldrich Syndrome, a rare X-linked immunodeficiency characterized by eczema, recurrent infections, and thrombocytopenia. The importance of WAS protein in immune responses has driven extensive research into its structure and function. Understanding the mechanisms by which WAS protein affects actin dynamics is crucial for unraveling how its dysfunction leads to the clinical manifestations of the syndrome. Additionally, studies on WAS protein have implications for gene therapy and potential treatments for related immune disorders. Recent advancements in recombinant protein technology have facilitated the production of WAS protein, allowing researchers to explore its role in cellular processes and its potential as a therapeutic target. By investigating WAS protein's interactions and pathways, scientists aim to develop new strategies for managing Wiskott-Aldrich Syndrome and enhancing our knowledge of immune system regulation.
